These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27133597)

  • 1. Regulatory T cell therapy for type 1 diabetes: May the force be with you.
    Gitelman SE; Bluestone JA
    J Autoimmun; 2016 Jul; 71():78-87. PubMed ID: 27133597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 1 diabetes immunotherapy using polyclonal regulatory T cells.
    Bluestone JA; Buckner JH; Fitch M; Gitelman SE; Gupta S; Hellerstein MK; Herold KC; Lares A; Lee MR; Li K; Liu W; Long SA; Masiello LM; Nguyen V; Putnam AL; Rieck M; Sayre PH; Tang Q
    Sci Transl Med; 2015 Nov; 7(315):315ra189. PubMed ID: 26606968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes.
    Marek-Trzonkowska N; Myśliwiec M; Iwaszkiewicz-Grześ D; Gliwiński M; Derkowska I; Żalińska M; Zieliński M; Grabowska M; Zielińska H; Piekarska K; Jaźwińska-Curyłło A; Owczuk R; Szadkowska A; Wyka K; Witkowski P; Młynarski W; Jarosz-Chobot P; Bossowski A; Siebert J; Trzonkowski P
    J Transl Med; 2016 Dec; 14(1):332. PubMed ID: 27903296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice.
    Amatya C; Radichev IA; Ellefson J; Williams M; Savinov AY
    Mol Ther; 2018 Jan; 26(1):184-198. PubMed ID: 28988715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cells in type 1 diabetes: Instructors, regulators and effectors: A comprehensive review.
    Gomez-Tourino I; Arif S; Eichmann M; Peakman M
    J Autoimmun; 2016 Jan; 66():7-16. PubMed ID: 26343335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes.
    Tenspolde M; Zimmermann K; Weber LC; Hapke M; Lieber M; Dywicki J; Frenzel A; Hust M; Galla M; Buitrago-Molina LE; Manns MP; Jaeckel E; Hardtke-Wolenski M
    J Autoimmun; 2019 Sep; 103():102289. PubMed ID: 31176558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive review.
    Tan T; Xiang Y; Chang C; Zhou Z
    Clin Rev Allergy Immunol; 2014 Oct; 47(2):234-43. PubMed ID: 25086642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of Autoimmune T-Cell Memory by Stem Cell Educator Therapy: Phase 1/2 Clinical Trial.
    Delgado E; Perez-Basterrechea M; Suarez-Alvarez B; Zhou H; Revuelta EM; Garcia-Gala JM; Perez S; Alvarez-Viejo M; Menendez E; Lopez-Larrea C; Tang R; Zhu Z; Hu W; Moss T; Guindi E; Otero J; Zhao Y
    EBioMedicine; 2015 Dec; 2(12):2024-36. PubMed ID: 26844283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus.
    Barcala Tabarrozzi AE; Castro CN; Dewey RA; Sogayar MC; Labriola L; Perone MJ
    Clin Exp Immunol; 2013 Feb; 171(2):135-46. PubMed ID: 23286940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice.
    Lo J; Xia CQ; Peng R; Clare-Salzler MJ
    J Immunol Res; 2018; 2018():5463879. PubMed ID: 29651443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of type 1 diabetes.
    Li L; Yi Z; Tisch R; Wang B
    Arch Immunol Ther Exp (Warsz); 2008; 56(4):227-36. PubMed ID: 18726144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity.
    Romano M; Fanelli G; Albany CJ; Giganti G; Lombardi G
    Front Immunol; 2019; 10():43. PubMed ID: 30804926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up.
    Marek-Trzonkowska N; Myśliwiec M; Dobyszuk A; Grabowska M; Derkowska I; Juścińska J; Owczuk R; Szadkowska A; Witkowski P; Młynarski W; Jarosz-Chobot P; Bossowski A; Siebert J; Trzonkowski P
    Clin Immunol; 2014 Jul; 153(1):23-30. PubMed ID: 24704576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling dynamic changes in type 1 diabetes progression: quantifying beta-cell variation after the appearance of islet-specific autoimmune responses.
    Nelson P; Smith N; Ciupe S; Zou W; Omenn GS; Pietropaolo M
    Math Biosci Eng; 2009 Oct; 6(4):753-78. PubMed ID: 19835428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXP3+ Regulatory T Cell Compartment Is Altered in Children With Newly Diagnosed Type 1 Diabetes but Not in Autoantibody-Positive at-Risk Children.
    Viisanen T; Gazali AM; Ihantola EL; Ekman I; Näntö-Salonen K; Veijola R; Toppari J; Knip M; Ilonen J; Kinnunen T
    Front Immunol; 2019; 10():19. PubMed ID: 30723474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.
    Jalili RB; Zhang Y; Hosseini-Tabatabaei A; Kilani RT; Khosravi Maharlooei M; Li Y; Salimi Elizei S; Warnock GL; Ghahary A
    PLoS One; 2016; 11(1):e0146970. PubMed ID: 26765526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells.
    Zhao Y; Jiang Z; Zhao T; Ye M; Hu C; Yin Z; Li H; Zhang Y; Diao Y; Li Y; Chen Y; Sun X; Fisk MB; Skidgel R; Holterman M; Prabhakar B; Mazzone T
    BMC Med; 2012 Jan; 10():3. PubMed ID: 22233865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting regulatory T cells in the treatment of type 1 diabetes mellitus.
    Cabrera SM; Rigby MR; Mirmira RG
    Curr Mol Med; 2012 Dec; 12(10):1261-72. PubMed ID: 22709273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mRNA expression of pro- and anti-inflammatory cytokines in T regulatory cells in children with type 1 diabetes.
    Łuczyński W; Stasiak-Barmuta A; Juchniewicz A; Wawrusiewicz-Kurylonek N; Iłendo E; Kos J; Kretowski A; Górska M; Chyczewski L; Bossowski A
    Folia Histochem Cytobiol; 2010 Jan; 48(1):93-100. PubMed ID: 20529823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro assessment of cord blood-derived proinsulin-specific regulatory T cells for cellular therapy in type 1 diabetes.
    Paul M; Dayal D; Bhansali A; Dhaliwal L; Sachdeva N
    Cytotherapy; 2018 Nov; 20(11):1355-1370. PubMed ID: 30340983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.